An optimized short-term steroid therapy for chronic drug-induced liver injury: A prospective randomized clinical trial.

Ang HuangYun ZhuShuhong LiuYing SunZherui LiuQing-Sheng LiangJun ZhaoBin-Xia ChangJing-Feng BiJiang-Tao Liu Xing-Ran ZhaiHuan XieNing LiHui TianLin HanYingjie ZhuangHongbin MaGuang-Ju TengWei ZhangGuruprasad Padur Aithal Dong Ji Jing-Min Zhao Zheng-Sheng Zou

Published in: Liver international : official journal of the International Association for the Study of the Liver (2024)

Both the 36- and 48-week SSR regimens demonstrated similar biochemical response and histological improvements with good safety, supporting 36-week SSR as a preferable therapeutic choice (ClinicalTrials.gov, NCT03266146).

Keyphrases

clinical trial
genetic diversity
placebo controlled
phase ii
study protocol
open label
randomized controlled trial
emergency department
adverse drug
phase iii
decision making